| 1,5,7,8-TETRAHYDRO-2-METHYL-4H-THIOPYRANO[4,3-D]PYRIMIDIN-4-ONE |
3,5,7,8-四氢-2-甲基-4H-硫代吡喃并[4,3-D]嘧啶-4-酮 |
284028-90-6 |
| AAL-993 |
AAL-993 |
269390-77-4 |
| MS 245 oxalate |
MS 245 OXALATE |
263384-65-2 |
| 2-[(1R)-1-[[(4-chlorophenyl)sulfonyl](2,5-difluorophenyl)amino]ethyl]-5-fluoroBenzenebutanoic acid |
2-[(1R)-1-[[(4-氯苯基)磺酰基](2,5-二氟苯基)氨基]乙基]-5-氟苯丁酸 |
290315-45-6 |
| 1-(3,6-DIBROMO-9H-CARBAZOL-9-YL)-3-(DIMETHYLAMINO)PROPAN-2-OL |
WISKOSTATIN |
253449-04-6 |
| H-ARG-PRO-ARG-LEU-SER-HIS-LYS-GLY-PRO-MET-PRO-PHE-OH |
ARG-PRO-ARG-LEU-SER-HIS-LYS-GLY-PRO-MET-PRO-PHE |
229961-08-4 |
| N1-[(1S)-2,2-Dimethyl-1-[[[(1R)-1-phenylethyl]amino]carbonyl]propyl]-N4-hydroxy-2-[3-(2-methyl[1,1'-biphenyl]-4-yl)propyl]-butanediamine |
UK 356618 |
230961-08-7 |
| D-LUCIFERIN 1-(4,5-DIMETHOXY-2-NITROPHENYL)ETHYL ESTER |
D-荧光素(DMNPE笼闭),酶底物 |
223920-67-0 |
| AC-IETD-PNA |
AC-ILE-GLU-THR-ASP-PNA |
219138-21-3 |
| PYR-ARG-PRO-ARG-LEU-SER-HIS-LYS-GLY-PRO-MET-PRO-PHE-OH |
人牛吡啶APELIN-13 |
217082-60-5 |
| CP 471,474 |
2-[[[4-(4-氟苯氧基)苯基]磺酰基]氨基] -N-羟基-2-甲基丙酰胺 |
210755-45-6 |
| 5-Heptenoic acid, 7-[(1R,2R,3S,5S)-2-[[(5-hydroxybenzo[b]thien-3-yl) |
治疗哮喘药物S-5751中间体 |
209268-36-0 |
| CASPASE-8 INHIBITOR II |
CASPASE-8抑制剂 |
210344-98-2 |
| CYP3cide |
PF-4981517 |
1390637-82-7 |
| PF-04554878 |
DEFACTINIB (VS-6063, PF-04554878) |
1345713-71-4 |
| 4′-[[2,3-Dimethyl-5-[[[(1S)-1-(4-nitrophenyl)ethyl]amino]carbonyl]-1H-indol-1-yl]methyl]- [1,1′-Biphenyl]-2-carboxylic acid |
4′-[[2,3-Dimethyl-5-[[[(1S)-1-(4-nitrophenyl)ethyl]amino]carbonyl]-1H-indol-1-yl]methyl]- [1,1′-Biphenyl]-2-carboxylic acid |
1338259-05-4 |
| GB 83 |
GB 83 |
1252806-86-2 |
| BMN 673 (8R,9S) |
(8R,9S)-5-氟-8-(4-氟苯基)-2,7,8,9-四氢-9-(1-甲基-1H-1,2,4-三唑-5-基)-3H-吡啶并[4,3,2-DE]酞嗪-3-酮 |
1207456-00-5 |
| AMG 232 |
2-((3R,5R,6S)-5-(3-氯苯基)-6-(4-氯苯基)-1-((S)-1-(异丙基磺酰基)-3-甲基丁烷-2-基)-3-甲基-2-氧代哌啶-3-基)乙酸 |
1352066-68-2 |
| PF-04217903 |
4-[1-(6-喹啉基甲基)-1H-1,2,3-三唑并[4,5-B]吡嗪-6-基]-1H-吡唑-1-乙醇 4-羟基苯磺酸盐 |
1159490-85-3 |
